{"id":64234,"date":"2025-02-01T00:01:31","date_gmt":"2025-02-01T00:01:31","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/02\/01\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/"},"modified":"2025-02-01T00:01:31","modified_gmt":"2025-02-01T00:01:31","slug":"gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/","title":{"rendered":"GH Research to Provide Update on Phase 2b Trial with GH001 in TRD"},"content":{"rendered":"<div>\n<p align=\"justify\">DUBLIN, Jan.  31, 2025  (GLOBE NEWSWIRE) &#8212; GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced that it will host a conference call and live webcast on Monday, February 3, 2025, at 8.00 a.m. EST to provide an update on data from the randomized, double-blind, placebo-controlled Phase 2b trial of GH001 in treatment-resistant depression (TRD).<\/p>\n<p align=\"justify\">To access the conference call, please register in advance <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A0EYFPjq2yxqBGeszPuaX9p7DapYADweuQSqjrhoLkAJlltWlxQiRJUMzkib233xV1LxfFRab6EttXQHrMICx9LhYMcd92ccLUrOG1ITVX8=\" rel=\"nofollow\" target=\"_blank\" title=\"here\">here<\/a>. A live webcast of the call will be available under \u201cEvents &amp; Presentations\u201d in the Investors section of GH Research PLC\u2019s website at ghres.com.<\/p>\n<p><strong>About GH Research PLC <\/strong><\/p>\n<p align=\"justify\">GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC&#8217;s initial focus is on developing its novel and proprietary mebufotenin therapies for the treatment of patients with treatment-resistant depression (TRD).<\/p>\n<p><strong>About GH001<\/strong><\/p>\n<p align=\"justify\">Our lead product candidate, GH001, is formulated for mebufotenin administration via a proprietary inhalation approach. Based on the observed clinical activity in our completed phase 1\/2 GH001-TRD-102 trial, where 87.5% of patients with TRD achieved ultra-rapid remission with our GH001 individualized single-day dosing regimen in the Phase 2 part of the trial, we believe that GH001 has the potential to change the way TRD is treated today.<\/p>\n<p><strong>Investor Relations<\/strong><br \/>Julie Ryan<br \/>GH Research PLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ddCwFGLqyFtfdEgW8bQZLEZY2Yb1hSuGjLmwATK5yLsPFkThIhBqPTPn4Kui665es7CeujSmkcMHsnLh9cYz5evXnJ8R5VyOID4gjVL_4o4=\" rel=\"nofollow\" target=\"_blank\" title=\"investors@ghres.com\">investors@ghres.com<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZGUzMjA2MGMtNDIzMi00YWFkLTgwMGMtYTcwYjhlYzU5ODcwLTEyMjIyMDQ=\/tiny\/GH-Research-PLC.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN, Jan. 31, 2025 (GLOBE NEWSWIRE) &#8212; GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced that it will host a conference call and live webcast on Monday, February 3, 2025, at 8.00 a.m. EST to provide an update on data from the [&#8230;]\n","protected":false},"author":1,"featured_media":64235,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-64234","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>GH Research to Provide Update on Phase 2b Trial with GH001 in TRD - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GH Research to Provide Update on Phase 2b Trial with GH001 in TRD\" \/>\n<meta property=\"og:description\" content=\"DUBLIN, Jan. 31, 2025 (GLOBE NEWSWIRE) &#8212; GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming th\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-01T00:01:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/GH-Research-PLC.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"GH Research to Provide Update on Phase 2b Trial with GH001 in TRD\",\"datePublished\":\"2025-02-01T00:01:31+00:00\",\"dateModified\":\"2025-02-01T00:01:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/\"},\"wordCount\":234,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/\",\"name\":\"GH Research to Provide Update on Phase 2b Trial with GH001 in TRD - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-02-01T00:01:31+00:00\",\"dateModified\":\"2025-02-01T00:01:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GH Research to Provide Update on Phase 2b Trial with GH001 in TRD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GH Research to Provide Update on Phase 2b Trial with GH001 in TRD - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/","og_locale":"en_US","og_type":"article","og_title":"GH Research to Provide Update on Phase 2b Trial with GH001 in TRD","og_description":"DUBLIN, Jan. 31, 2025 (GLOBE NEWSWIRE) &#8212; GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming th","og_url":"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-02-01T00:01:31+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/GH-Research-PLC.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"GH Research to Provide Update on Phase 2b Trial with GH001 in TRD","datePublished":"2025-02-01T00:01:31+00:00","dateModified":"2025-02-01T00:01:31+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/"},"wordCount":234,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/","url":"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/","name":"GH Research to Provide Update on Phase 2b Trial with GH001 in TRD - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-02-01T00:01:31+00:00","dateModified":"2025-02-01T00:01:31+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/gh-research-to-provide-update-on-phase-2b-trial-with-gh001-in-trd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"GH Research to Provide Update on Phase 2b Trial with GH001 in TRD"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=64234"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64234\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/64235"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=64234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=64234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=64234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}